Wessex makes case for life sciences investment as Government backs regional innovation clusters

Wessex life sciences leaders are calling for the region to secure greater national recognition and investment following the Government’s £1 billion commitment to develop world-leading innovation clusters across the UK.

18/11/26

With government seeking to back regions which best combine research excellence, innovative businesses and skilled people, Wessex used a parliamentary reception on 17 November to demonstrate its globally significant life sciences cluster. 

The event, convened by Health Innovation Wessex and hosted by the Rt Hon Kit Malthouse MP, presented Wessex as a vibrant life sciences super-cluster connecting discovery, development, adoption and commercial impact across Hampshire and the Isle of Wight, Dorset and South Wiltshire.

The region has more than 300 life sciences businesses, around 24,400 sector employees and a yearly pipeline of over 5,000 life sciences graduates. Its seven universities, NHS organisations, research facilities and growing science parks give Wessex nationally significant strengths ranging from vaccine development, cancer treatments and genomics research to new ways of tackling antibiotic-resistant infections, advanced light-based diagnostics and responsible use of AI in healthcare.

  • From left to right: Ceri (research participant), Nicola Bent (CEO, Health Innovation Wessex), Paul Holmes MP (Hamble Valley), Clare (research participant), Christine McGrath (MD, Wessex Health Partners), Kit Malthouse MP (North West Hampshire)

  • Damian Hinds MP (East Hampshire) meets the team from iFAST and their diagnostic innovations

  • Kit Malthouse MP (North West Hampshire) giving the keynote speech

  • Gareth Griffiths, Professor of Clinical Trials, Southampton Clinical Trials Unit and Caroline Nokes MP (Romsey and Southampton North)

  • Danny Chambers MP (Winchester) meets the team from Cyted Health

  • Danny Chambers (MP for Winchester) adds bacteria to create a biofilm at the stand run by National Biofilms Innovation Centre

  • Kit Malthouse MP (North West Hapmshire), at the LifeLight stand, checking his blood pressure via phone camera

  • Amrit Bason (Strategic Account Manager, Novartis) and Dr Lara Alloway (Chief Medical Officer, NHS Hampshire and Isle of Wight ICB) meeting members of the iFAST team

  • Wessex Life Sciences map and key

Kit Malthouse MP, Chair, All-Party Parliamentary Group for Life Sciences and Member, Science, Innovation and Technology Select CommitteeKit Malthouse MP, Chair, All-Party Parliamentary Group for Life Sciences and Member, Science, Innovation and Technology Select Committee, said: “Britain has a genuine gift for discovery. Our challenge has often been turning that brilliance into products, jobs and better health. In Wessex, that challenge is being met with energy and ambition, where ideas are moved from laboratory to patient at

The region's investment pipeline includes 

  • Proposed £100 million Institute for Medical Innovation to accelerate medical breakthroughs
  • £16 million high-spec Infinity Labs development at University of Southampton Science Park 
  • £10 million specialist manufacturing facility in Southampton (subject to final agreements) to enable bacteriophage production (viruses which destroy bacteria) – investment by Slovenian company Jafral supported by LEP legacy funding via Hampshire Prosperity Partnership

These developments sit within a regional life sciences economy generating £6.3 billion in annual turnover.

The region is successfully partnering with industry to deliver world-changing research and innovation. Respiratory syncytial virus (RSV) is a major cause of infant hospital admissions, adding significant pressure to paediatric beds and already stretched NHS services. The Wessex-led HARMONIE study showed an 83% reduction in RSV-related hospital admissions among participating babies. More than 11 million children have now received the winter jab and the treatment is approved in more than 50 countries. 

The event also highlighted commercial successes which have contributed employment and growth for the region. 

  • Southampton-founded Lifelight has developed a medical device that measures blood pressure and other vital signs using a smartphone. Support from the Wessex innovation ecosystem helped the company build evidence, secure more than £3.5 million in funding and win international contracts.
  • iFAST Diagnostics, a University of Southampton spin-out, has developed technology which can identify antibiotics likely to work against infections in under three hours, helping clinicians make faster treatment decisions for seriously ill patients.

Nicola Bent, Chief Executive, Health Innovation WessexNicola Bent, Chief Executive of Health Innovation Wessex, said: “Wessex can develop, evaluate and adopt innovation in real-world settings. That connected route from evidence to implementation is valuable to the NHS and to companies seeking a place to test, prove and scale.”

Christine McGrath, Managing Director, Wessex Health PartnersChristine McGrath, Managing Director of Wessex Health Partners, added: “This is a business and growth story as much as a health story. Wessex offers talent, infrastructure, clinical validation and a track record of turning excellent science into products, jobs and impact.”

Partners want MPs to champion Wessex in national policy, connect regional leaders with ministers and investors, and support continued investment in research infrastructure, secure data and innovation districts.

Find out more at www.wessexpledge.org

More articles

See all news